Eagle's Eye View: Day 1 Highlights | TCT 2019

Sep 26, 2019   |  Peter C. Block, MD, FACC; Spencer B. King III, MD, MACC

Podcast

Font Size
A
A
A

In this special episode of the View, Dr. Peter Block and Dr. Spencer King discuss highlights from Day 1 of TCT.19, including apixaban vs. warfarin and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndromes (AUGUSTUS ACS) and ticagrelor monotherapy vs. ticagrelor-plus-aspirin in high-risk percutaneous coronary intervention (TWILIGHT).

Subscribe on iTunes | Subscribe on Google Play

Connect with colleagues attending TCT: Join the conversation on Member Hub!

Please log into ACC.org to participate. Not a member? Join the ACC today and discover how membership connects you to the network, education and resources you need to provide quality cardiovascular care.

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Interventions and ACS, Interventions and Imaging, Angiography, Nuclear Imaging

Keywords: EaglesEyeView, Transcatheter Cardiovascular Therapeutics, TCT19, Aspirin, Percutaneous Coronary Intervention, Angiography, Coronary Angiography, Warfarin, Atrial Fibrillation, Acute Coronary Syndrome


< Back to Listings